Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
Atherosclerosis: Identifying risks and improving outcomes

Atherosclerosis: Identifying risks and improving outcomes

Atherosclerosis: Identifying risks and improving outcomes

Atherosclerosis: Identifying risks and improving outcomes

Atherosclerosis: Identifying risks and improving outcomes

Atherosclerosis: Identifying risks and improving outcomes

Atherosclerosis: Identifying risks and improving outcomes

Atherosclerosis: Identifying risks and improving outcomes

Atherosclerosis: Identifying risks and improving outcomes

Atherosclerosis: Identifying risks and improving outcomes

Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

Ticagrelor vs Clopidogrel in Older Patients With ACS PCI

Ticagrelor vs Clopidogrel in Older Patients With ACS PCI